{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04642820",
            "orgStudyIdInfo": {
                "id": "IRB20-0364"
            },
            "organization": {
                "fullName": "University of Chicago",
                "class": "OTHER"
            },
            "briefTitle": "Drugs Brain and Behavior (DDP)",
            "officialTitle": "Drugs Brain and Behavior",
            "acronym": "DDP",
            "therapeuticArea": [
                "Other"
            ],
            "study": "drugs-brain-and-behavior-ddp"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-12",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2020-11-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2023-10-01",
                "type": "ACTUAL"
            },
            "completionDateStruct": {
                "date": "2024-06-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-11-18",
            "studyFirstSubmitQcDate": "2020-11-18",
            "studyFirstPostDateStruct": {
                "date": "2020-11-24",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-12-08",
            "lastUpdatePostDateStruct": {
                "date": "2023-12-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Chicago",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "In this project, we will examine individual differences in the effects of a stimulant drug, methamphetamine (MA), on mesolimbic reward function using fMRI."
        },
        "conditionsModule": {
            "conditions": [
                "Stimulant Use"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 160,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Placebo Then Methamphetamine",
                    "type": "EXPERIMENTAL",
                    "description": "Participants first receive placebo at their first session in the laboratory. Then will return to the laboratory 72 hours later and will receive 20 mg methamphetamine.",
                    "interventionNames": [
                        "Drug: Methamphetamine",
                        "Drug: placebo oral tablet"
                    ]
                },
                {
                    "label": "MethamphetamineThen Placebo",
                    "type": "EXPERIMENTAL",
                    "description": "Participants first receive 20 mg methamphetamine at their first session in the laboratory Then will return to the laboratory 72 hours later and will receive placebo.",
                    "interventionNames": [
                        "Drug: Methamphetamine",
                        "Drug: placebo oral tablet"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Methamphetamine",
                    "description": "Participants will be given 20 mg of Methamphetamine.",
                    "armGroupLabels": [
                        "MethamphetamineThen Placebo",
                        "Placebo Then Methamphetamine"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "placebo oral tablet",
                    "description": "Participants will be given a placebo capsule that will only contain lactose.",
                    "armGroupLabels": [
                        "MethamphetamineThen Placebo",
                        "Placebo Then Methamphetamine"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in SUbjective Effects as Assessed by Score on \"Feel Drug\", \"Feel High\", \"Like Drug\", and \"Want More\" Sub-scales of Drug Effects Questionnaire (DEQ).",
                    "description": "Participants will complete The Drug Effects Questionnaire during the initial baseline session to determine their subjective stimulant profile. The Dug Effects Questionnaire (DEQ) is a visual analog scale questionnaire that assesses the extent to which subjects experience four subjective states: \"Feel Drug\", \"Feel High\", \"Like Drug\", and \"Want More\". All sub-scales are scored on a visual analogue scale (Scroll bar on computer screen) ranging from 0-100. 100 represents the highest score for that subjective state, and the higher the score, the worse the outcome.",
                    "timeFrame": "Time Frame: Day 1(baseline), 3"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* BMI between 19 and 26\n* Right Handed\n* Less than 4 alcohol or caffeinated beverages a day.\n\nExclusion Criteria:\n\n* High blood pressure\n* Any medical condition requiring regular medication\n* Individuals with a current (within the last year) DSM-IV Axis 1 diagnosis\n* Individuals with a history of dependence on stimulant drugs\n* Women who are pregnant or trying to become pregnant.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "35 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Matthew Bona",
                    "role": "CONTACT",
                    "phone": "773-702-3560",
                    "email": "dewitlab@yoda.bsd.uchicago.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Harriet de Wit",
                    "affiliation": "Principal Investigator",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Chicago",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60637",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Matthew Bona",
                            "role": "CONTACT",
                            "email": "dewitlab@yoda.bsd.uchicago.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008694",
                    "term": "Methamphetamine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000697",
                    "term": "Central Nervous System Stimulants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000013566",
                    "term": "Sympathomimetics"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000015259",
                    "term": "Dopamine Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000018663",
                    "term": "Adrenergic Agents"
                },
                {
                    "id": "D000018759",
                    "term": "Adrenergic Uptake Inhibitors"
                },
                {
                    "id": "D000014179",
                    "term": "Neurotransmitter Uptake Inhibitors"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000018765",
                    "term": "Dopamine Uptake Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11674",
                    "name": "Methamphetamine",
                    "asFound": "Grasping",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4029",
                    "name": "Central Nervous System Stimulants",
                    "relevance": "LOW"
                },
                {
                    "id": "M16345",
                    "name": "Sympathomimetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M7473",
                    "name": "Dopamine",
                    "relevance": "LOW"
                },
                {
                    "id": "M17962",
                    "name": "Dopamine Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20746",
                    "name": "Adrenergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20832",
                    "name": "Dopamine Uptake Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "CNSSti",
                    "name": "Central Nervous System Stimulants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "CaAg",
                    "name": "Cardiotonic Agents"
                }
            ]
        }
    },
    "hasResults": false
}